STAT3 and neoplasm: Mechanically, EVs released from NSCLC cells can induce anaplastic lymphoma kinase inhibitors-resistant or Ceritinib-resistant phenotype upon target tumor cells via stimulating AKT, STAT3 and ERK pathways (Wu et al., 2018).